Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety
Publikation: Bidrag til tidsskrift › Review › fagfællebedømt
Dokumenter
- Guselkumab for hidradenitis suppurativa in a patient with concomitant
Forlagets udgivne version, 451 KB, PDF-dokument
Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Clinical Case Reports |
| Vol/bind | 8 |
| Udgave nummer | 12 |
| Sider (fra-til) | 2874-2877 |
| Antal sider | 4 |
| ISSN | 2050-0904 |
| DOI | |
| Status | Udgivet - 2020 |
Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk
Ingen data tilgængelig
ID: 249860508